Latest II diabetes Stories
Poor maternal diet before conception can result in offspring with reduced birth weights and increased risk of developing type II diabetes and obesity.
TAIPEI, Taiwan, June 14, 2011 /PRNewswire-Asia/ -- TWi Biotechnology Inc. announced today that the company has enrolled over 50% of the total 240 patients for the Phase IIb clinical trial of AC-201 for the treatment of Type II Diabetes.
For over ten years certified nutritionist and exercise specialist Isabel De Los Rios has helped dieters understand the long term health and weight loss benefits of eating high quality foods for preventative care against diseases such as Type II Diabetes.
BHV Pharmaceuticals, a clinical-stage drug development company, announced today it has entered into a license agreement with Kissei Pharmaceutical Co. Ltd. for exclusive rights to develop and commercialize Remogliflozin Etabonate, a novel, highly selective SGLT2 inhibitor.
Hyperglycemia during critical illness may be used as a warning of future diabetes.
SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications.
The research, published online Jan. 31, 2010, in the journal Nature Genetics, presents the first high-resolution atlas of these regulatory elements in the most studied cell type for treatment and prevention of type II diabetes.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institute published in Cell Metabolism.
Research Presented at Experimental Biology 2009 Reveals Cardiovascular and Glycemic Control Benefits of Pistachios NEW ORLEANS, April 22 /PRNewswire/ -- Pistachios are much more than a great-tasting snack.
A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient satisfaction.